— Hochmodernes Zentrum für Entwicklungs-, Anwendungs- und Sensoriklabore
— Bezug des bekannten Gold Tower in DMCC, JLT, für Aktivitäten im Nahen Osten, Pakistan und Afrika
— Unterstützt vier Säulen der Nachhaltigkeit und den Weg zum klimaneutralen Unternehmen Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-weiht-innovationszentrum-in-dubai-ein-mehr-nachhaltiger-und-lokaler-geschmack-fuer-die-regio-1/
Autobahn Labs incubator announces partnership with Cold Spring Harbor Laboratory to advance novel science to the clinic
Autobahn Labs, an early-stage drug discovery incubator, today announced a new strategic venture collaboration with Cold Spring Harbor Laboratory (CSHL). Together with Autobahn Labs, CSHL will identify promising research programs with therapeutic potential and partner to form promising new drug discovery companies. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/autobahn-labs-incubator-announces-partnership-with-cold-spring-harbor-laboratory-to-advance-novel-science-to-the-clinic-6068
Symrise Diana Food präsentiert Rezeptvideos für seine natürlichen kulinarischen Geschmackslösungen
― Videos verfügbar ab 1. Juni 2021
― Zu einer kulinarischen Reise um die Welt inspirieren Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-diana-food-praesentiert-rezeptvideos-fuer-seine-natuerlichen-kulinarischen-geschmacksloesungen/
Symrise investiert in Pflegeserie für naturkrauses Haar von Infinite Looks
— Finanzierung einer Kapitalerhöhung von 4,2 Millionen US Dollar im wachsenden Segment der ethnischen Haarpflege
— Ausweiten der Marktkenntnisse sowie Entwickeln maßgeschneiderter Haarpflegeprodukte
— Fokus auf Produkte für sportlich aktive Frauen mit krausem Haar Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-investiert-in-pflegeserie-fuer-naturkrauses-haar-von-infinite-looks/
How the Meticulous Researcher Validates Their Cell Counting Method
– 6 min read
Yes, Meticulous Researchers validate their cell counting method! It’s what qualifies them as being meticulous… Did you ever do it, though?
You can benefit a lot from validating your cell counting method. First and foremost, if you have confidence that your cell count is correct, you can trust your data and won’t lose sleep over at least THAT parameter of your setup and results.
The Meticulous Researchers know, and we created this cheat-sheet to see how they work.
1. They know the difference between accuracy and precision
These are the basics to be on top of in cell counting. If you want to validate the precision and accuracy of your own cell counting instrument, it is best done by validating the linearity of your cell count through a 1:1 dilution series and ensuring that your results are linear, i.e., that your R2 is close to 1.0.
2. They know their working range and linearity of viability
Meticulous Researchers have tested the outer boundaries of cell concentrations at which they can count cells in a linear range, i.e. count with confidence. They have also mixed living and dead cells at different known ratios and tested whether the instrument actually does identify the cells as living or dead.
3. They have tested the instrument-to-instrument variability
When using different cell counting instruments across the production and quality control processes, it is crucial that data validated at one point can be compared to data at a different process point, so you can get an overall picture of the production run and validate the performance. The Meticulous Researcher did this in their instrument validation through extensive replica testing. Boring, yes. But extremely satisfying when you just KNOW that your instruments are aligned.
4. They know their people’s strengths and weaknesses
Meticulous Researchers know whether one lab member counts differently from the other and whether this is due to sample handling, instrument operation or something else. They have tested it, they analyzed the data, they know. They just KNOW! Inter- and intra-operator variation can kill a production run.
5. They know their instrument’s strengths and weaknesses
The Meticulous Researcher also knows whether any contaminants of their cell culture production run potentially affects their cell counting method. Yes, of course they tested this as well – they test everything!
Get the webinar on refining your cell counting method
Our Field Application Scientists (FAS) get questions from many of our customers on how to validate their cell counting method. Luckily, they know how the Meticulous Researcher does this. We hosted a webinar with a full guide, so you can follow the same methodology of the Meticulous Researcher: How Precise are Your Cell Counts? It’s not hard at all, it just takes time and dedication, and you will know all about how much you can trust your cell counter.
Further Reading
- How the Via2-Cassette™ technology eliminates human error from cell counting
- Viral gene therapy for rare skin disorders at Krystal Biotech
- How our automated cell counting instrument performs compared to manual cell counting
- Hitachi Chemical generates T cell therapies using stirred-tank bioreactors
- Watch our webinars to learn more about automated cell counting
By Janny Marie L Peterslund, Scientific Affairs Manager at ChemoMetec
Janny Marie has a background in stem cell research at Novo Nordisk, Denmark. She worked at STEMCELL Technologies, supporting and managing the epithelial cell culture product portfolio. Now at ChemoMetec, Janny Marie supports collaborations with external partners and writes for the Cell Counting Blog.
Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://chemometec.com/how-the-meticulous-researcher-validates-their-cell-counting-method/
Internationaler Tag der Biodiversität – Symrise engagiert sich
— Förderung nachhaltiger Biodiversitätsinitiativen auf globaler Ebene
— Verantwortungsvolle Beschaffung biologischer Ressourcen durch nachhaltige Rückwärtsintegration
— Biologische Vielfalt essenzielle Lebensgrundlage und Grundpfeiler für Duft, Geschmack, Ernährung und Pflege
— Ausbau der Vorreiterrolle im Schutz von Biodiversität und nachhaltiger Unternehmenstätigkeit Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/internationaler-tag-der-biodiversitaet-symrise-engagiert-sich/
Evotec SE reports results for the first quarter 2021 and provides corporate update
Evotec SE today announced the financial results and corporate updates for the first quarter 2021. Group revenues from contracts with customers increased by 11% to € 133.1 m (Q1 2020: € 119.4 m); Base business growth of 28%, adjusted for the end of the Sanofi payment (since April 2020) and unfavourable fx effects; EVT Execute revenue growth of 16% (11% adjusted for material recharges) to € 136.9 m (Q1 2020: € 118.2 m), EVT Innovate revenues up 21% (20% adjusted for material recharges) to € 28.2 m (Q1 2020: € 23.3 m) Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-reports-results-for-the-first-quarter-2021-and-provides-corporate-update-6066
Symrise unterzeichnet revolvierende Kreditlinie mit Nachhaltigkeitskomponente in Höhe von 500 Mio. €
— Revolvierende Kreditlinie ersetzt bestehende in Höhe von 300 Mio. € — Zinsmarge ist an drei Nachhaltigkeits-Kennzahlen zu Treibhausgas-Emissionen, Rohstoffbeschaffung und Wasserverbrauch gekoppelt
— Nachhaltigkeitsgebundene Anpassungen der Zinsmarge zugunsten von Projekten der Hilfsorganisation „Save the Children“ in Madagaskar Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.symrise.com/de/newsroom/artikel/symrise-unterzeichnet-revolvierende-kreditlinie-mit-nachhaltigkeitskomponente-in-hoehe-von-500-mio-EUR/
Evotec launches "beLAB1407" to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb
Evotec SE announced today that the Company, together with Bristol-Myers Squibb Company (NYSE: BMY), has launched beLAB1407, a new $ 20 m academic BRIDGE to identify and advance novel and breakthrough drug discovery opportunities across therapeutic areas from the UK’s top-tier academic institutions. Through a unique combination of Evotec’s drug discovery and development platforms and early-stage therapeutic concepts from the Universities of Birmingham, Edinburgh, Nottingham, and Dundee, beLAB1407 offers a unique route to the advancement of first-in-class therapeutics and the creation of spin-out companies. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-launches-belab1407-to-accelerate-translational-research-from-the-uks-academic-life-science-ecosystem-in-collaboration-with-bristol-myers-squibb-6064
Evotec SE to announce results for the first quarter 2021 on 11 May 2021
Evotec SE will announce its financial results for the first quarter of 2021 on Tuesday, 11 May 2021. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-to-announce-results-for-the-first-quarter-2021-on-11-may-2021-6061